Cannabis Wire caught up with the Canopy Growth founder and former CEO on his decision to join Vireo Health as executive chairman.
The former CEO of Canopy Growth could receive up to 15 million shares for his role at the multistate cannabis company.
Aphria Reports a Second Consecutive Profitable Quarter, While Some Investors Share Concern Over Canadian Market
During an earnings call on Tuesday, Aphria emphasized Canadian growth opportunities against what some investors see as a disappointing first year of adult-use sales in the country.
Stock exchanges in Canada, Australia, and Jamaica talk to Cannabis Wire about how closely they’re watching US cannabis legislation that could change the international economic landscape.
Less than ten months after the companies agreed that MedMen would acquire PharmaCann, one of the biggest deals in cannabis history came to an end.
What regions get to apply a geographical label to its cannabis? Does an international perspective help? Should a name be connected to the land?
More and more state financial institutions in California are banking or considering banking cannabis businesses, according to state officials.
The International Cannabis Bar Association hosted discussions on the interplay between countries that have tightly-regulated cannabis laws, and more lax ones.
Cannabis Wire co-founder interviews Barrington Miller, CSE director of listed client services, at the ArcView Group’s investor forum.
During a House Subcommittee hearing Wednesday, FDA and CDC officials told lawmakers that the majority of vaping related illness are linked to THC-based products.
Cannabis regulators grapple with how to react to the hundreds of mysterious vape-related illnesses and nine deaths across the US.
Cannabis Wire contacted major banks to learn whether they will work with cannabis businesses, or wait for federal prohibition to lift. Here’s what we learned.
Jurisdictions across California, Nevada, and Oregon are pushing for a national banking solution for cannabis businesses, as well as on other issues.
This is the first time the European Medicines Agency has approved a cannabis plant-based CBD medicine.
A number of regulators, legislators, and companies see it as a problem-solver, and the pace of adoption is picking up.
The court found that federal minimum wage and overtime laws apply even to businesses that break federal law.